£520.00

2023-2028 Endometrial Cancer Treatments Outlook - US Market

Price data last checked 63 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 28 days · 28 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 09 July 2026 15 July 2026 22 July 2026 29 July 2026 05 August 2026

Price Distribution

Price distribution over 28 days • 1 price levels

Days at Price
28 days 0 7 14 21 28 £520 Days at Price

Price Analysis

Most common price: £520 (28 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 28 days

Description

This comprehensive report analyses the evolving landscape of endometrial cancer treatments across the United States from 2023 through 2028. Published by ICON Group International, Inc., the outlook examines current clinical approaches, emerging therapeutic options, and market trends shaping patient care and treatment accessibility during this critical five-year period. Healthcare professionals, researchers, pharmaceutical companies, and policy makers will find detailed insights into treatment advancements, regulatory developments, and epidemiological shifts affecting endometrial cancer management in America. The report provides strategic intelligence for stakeholders navigating the healthcare sector's response to this significant gynaecological malignancy.

Key Features

Covers the 2023-2028 forecast period for endometrial cancer treatment developments in the United States market.

Published by ICON Group International, Inc., a recognised source for healthcare and market intelligence research.

Analyses treatment protocols, clinical outcomes, and therapeutic innovations affecting endometrial cancer care delivery.

Provides forecasted data on market trends and healthcare resource allocation for oncology treatments.

Designed for healthcare professionals, pharmaceutical companies, researchers, and healthcare policy stakeholders.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Endometrial Cancer Treatments in India
99% match

The 2023-2028 Outlook for Endometrial Cancer Treatments in India

£515.00 04 Aug 2026
2023-2028 Endometrial Cancer Treatments Outlook - China
99% match

2023-2028 Endometrial Cancer Treatments Outlook - China

£495.00 05 Aug 2026
Endometrial Cancer Treatments Outlook Japan 2023-2028
99% match

Endometrial Cancer Treatments Outlook Japan 2023-2028

£495.00 05 Aug 2026
2023 Endometrial Cancer Treatments Report - Global Market Analysis
99% match

2023 Endometrial Cancer Treatments Report - Global Market Analysis

£795.00 05 Aug 2026
The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers
98% match

The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers

£795.00 29 Sep 2026
The 2023-2028 Outlook for Endometrial Cancer Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Endometrial Cancer Treatments for US Zip Codes

£490.00 05 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 20 Aug 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
97% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 25 Aug 2026
The 2013-2018 Outlook for Endometriosis Treatments in the United States
97% match

The 2013-2018 Outlook for Endometriosis Treatments in the United States

£495.00 14 Aug 2026
2023 Chemotherapy Endometrial Cancers Report - Global Market Analysis
97% match

2023 Chemotherapy Endometrial Cancers Report - Global Market Analysis

£795.00 05 Aug 2026
The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City
97% match

The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City

£795.00 13 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 25 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 17 Sep 2026
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
97% match

The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics

Price unavailable
Cancer of the Uterine Endometrium - Advances and Controversies
97% match

Cancer of the Uterine Endometrium - Advances and Controversies

IntechOpen

£119.00 22 Sep 2026
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
97% match

The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

Price unavailable
The 2023-2028 Outlook for Gynecologic Oncology in the United States
97% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 28 Aug 2026
Recent Advances in Endometrial Cancer
97% match

Recent Advances in Endometrial Cancer

Springer

£72.98 11 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes

£490.00 21 Aug 2026
96% match

Atlas of Endometrial Pathology 1.0 on CD-ROM (Pathology Atlases on CD-ROM)

Price unavailable
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
Endometriosis: Recent Advances, New Perspectives and Treatments
96% match

Endometriosis: Recent Advances, New Perspectives and Treatments

IntechOpen

£119.00 26 Sep 2026